Comerica Bank’s Sutro Biopharma STRO Stock Holding History

Comerica Bank’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$35	Sell	3 -2	-40%	-$19	﹤0.01%	3697
2025 Q3	$42	Hold	5	–	–	﹤0.01%	3698
2025 Q2	$35	Hold	5	–	–	﹤0.01%	3681
2025 Q1	$32	Hold	5	–	–	﹤0.01%	3670
2024 Q4	$91	Hold	5	–	–	﹤0.01%	3650
2024 Q3	$170	Hold	5	–	–	﹤0.01%	3643
2024 Q2	$144	Hold	5	–	–	﹤0.01%	3672
2024 Q1	$277	Sell	5 -14	-74%	-$618	﹤0.01%	3703
2023 Q4	$802	Sell	19 -9	-32%	-$286	﹤0.01%	3642
2023 Q3	$971	Buy	+28	New	+$1.22K	﹤0.01%	3663

Other funds holding STRO

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Comerica Bank's STRO Position: Q4 2025 in Review

Comerica Bank reduced its Sutro Biopharma (STRO) stake by 40% in Q4 2025, selling an estimated $19 and leaving 3 shares worth $35. The position accounts for ﹤0.01% of the portfolio, ranked #3697.

Comerica Bank first reported a position in STRO in Q3 2023 and has held it in 10 quarters since. The position peaked at $971 in Q3 2023. 63 funds tracked by Wall St. Rank hold STRO as of Q4 2025.

Comerica Bank held 3 shares of Sutro Biopharma worth $35 as of Q4 2025.
Comerica Bank sold 2 Sutro Biopharma shares in Q4 2025, an estimated $19.
Sutro Biopharma made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3697 holding.
Comerica Bank first reported a position in Sutro Biopharma in Q3 2023 and has held it in 10 quarters since.
Comerica Bank's Sutro Biopharma position peaked at $971 in Q3 2023.
63 funds tracked by Wall St. Rank held Sutro Biopharma as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.